ro glp 1 sign in Launches Weight Loss Program With GLP-1 Medications, Lab Testing, 1:1 Coaching, and Personalized Provider Care Ro launches GLP-1 supply tracker

These outcomes are identical whether the medication is paid for by insurance or self-pay what matters clinically is consistent physician supervision and adherence

Summary: In Phase 2 clinical trials, retatrutide was typically initiated at 2 mg once weekly via subcutaneous injection, with gradual dose escalation over several months under close medical supervision

Self-administering an unverified version without medical oversight adds a layer of risk

(1) Best options: Focus on lean protein sources including poultry and wild-caught fish

Until now, the program wouldnt cover any GLP-1 weight loss drugs, such as Ozempic and Mounjaro, unless you were overweight and had another ailment that GLP-1s can treat, such as type 2 diabetes

The study revealed unprecedented adipose tissue reduction outcomes, particularly in participants receiving the highest 12 mg dose (Jastreboff et al., 2023): 24.2% average adipose tissue reduction at 48 weeks (~26.2 kg or 57.8 lbs)